STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,854,505 | -74.1% | 1,485,915 | -30.2% | 0.03% | -74.0% |
| Q2 2023 | $22,644,430 | +28.5% | 2,130,238 | +0.7% | 0.13% | +36.5% |
| Q1 2023 | $17,621,415 | +72.2% | 2,115,416 | +90.8% | 0.10% | +57.4% |
| Q4 2022 | $10,235,267 | +115.8% | 1,108,913 | +200.3% | 0.06% | +96.8% |
| Q3 2022 | $4,742,000 | – | 369,327 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $391,802,000 | 74.38% |
| RTW INVESTMENTS, LP | 3,544,248 | $84,459,000 | 2.38% |
| Cormorant Asset Management, LP | 1,701,292 | $40,542,000 | 1.55% |
| Redmile Group, LLC | 2,502,306 | $59,630,000 | 1.10% |
| RA Capital Management | 1,119,963 | $26,689,000 | 0.52% |
| HighVista Strategies LLC | 17,734 | $423,000 | 0.35% |
| GILDER GAGNON HOWE & CO LLC | 1,569,564 | $37,403,000 | 0.29% |
| Birchview Capital, LP | 20,000 | $477,000 | 0.29% |
| Perceptive Advisors | 671,978 | $16,013,000 | 0.26% |
| Artal Group S.A. | 285,000 | $6,792,000 | 0.19% |